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Many botanical compounds (“botanicals”) have the potential to prevent,
ameliorate, or even cure some common health perturbations. When the
beneficial plant materials or extracts derived from those materials are directed
toward specific therapies, they are frequently referred to as nutraceuticals. In
most cases, the acceptance of their therapeutic value has taken an inordinately
long time, even though the ratio of benefits to risks is often very high. Much
of␣ the delayed recognition of therapeutic potential can be attributed to poor
physician training in the basic rudiments of nutrition. In addition, the emphasis
among practitioners has consistently been on prescription pharmaceuticals,
not␣ on over-the-counter nutraceuticals. Accordingly, physicians offer statin-type
drugs to lower cholesterol rather than non-prescription garlic and soluble
fibers; sibutramine to aid weight loss rather than Garcinia cambogia. Moreover,
vitamins and antioxidants to maintain good health do not achieve the desired
professional appeal necessary for many practitioners. On the other hand, the
exaggerated, often preposterous, beneficial claims of many in the natural
products industry make it easier to comprehend why potentially useful plant
products have been overlooked or even dismissed for far too many years.
However, the pendulum is gradually swinging in the other direction, as more
and more patients are, through necessity, taking responsibility for their own
health. The policy of “getting them in and out as fast as possible,” emphasized
by many large health organizations in order to increase profit margins, has
made people aware that long-term health must, at least to some extent, become
their own concern rather than that of the health professional. This coincides
with a general recognition that, whereas modern medicine is good at treating
acute and catastrophic illnesses, this does not hold for preventive measures. In
certain vital areas of importance to health, such as obesity, where drug therapy
has been less than satisfactory in its effects or has caused unacceptable side
effects, natural products are fervently being sought as alternatives.
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There are many other important health areas where botanicals have proven
useful. In this discussion I will cite only some of the most promising of which
I␣ have first-hand knowledge.
MAITAKE MUSHROOM: IMMUNITY ENHANCER, TUMOR SUPPRESSOR,
ANTI-DIABETIC
Many natural compounds enhance nonspecific immunity, including biological
agents of varied chemical structure. Herbs such as astragalus and echinacea
have been documented to possess nonspecific immunity-modulating effects
(Physicians’ Desk Reference, 2000; Therapeutic Research Faculty, 2000).
Medicinal mushrooms, such as reishi, shiitake, cordyceps, and maitake, show
a␣ common ability to enhance immune function by stimulating cell-mediated
immunity (Lahnborg et al., 1982). Quite simply, mushrooms seem to turn on
cells in the immune system, including macrophages and T-cells, that appear
to␣ have significant cancer- and infection-fighting properties. This is primarily
because some mushrooms are an excellent source of beta-glucans, which are
non-digestible polysaccharides found in the cell walls (Borchers et al., 1999).
When beta-glucans are consumed prudently, significant benefits to immune
health are common. The immune system is reactivated, regaining the ability
to␣ fight disease and to ward off infection. These complex sugars are the
basis␣ of␣ multi-cellular immune intelligence—the ability of immune cells to
communicate, cohere, and work together to keep us healthy and balanced.
Concentrating on the maitake mushroom, a logical question to ask is how
does it work? Beta-glucans with certain molecular-branching configurations
have been shown to dock onto receptors on the outer walls of macrophages
and␣ activate them, stimulating the immune response to pathogens (Brown and
Gordon, 2001). Macrophages contain specific protein-based receptor complexes
on their walls to which the β-1,3/1,6-D-glucan molecule readily attaches. The
binding of β-1,3/1,6-D-glucan enhances the ability of macrophages to detect
and scavenge a variety of health threats. Bacterial infections respond remarkably
to these polysaccharides, as do many viral infections—from the common cold
and influenza to herpes and HIV. Beta-glucans even mitigate the toxic effects
of␣ radiation and chemotherapy while augmenting their cancer-killing effects,
resulting in prolonged survival and improved quality of life for cancer patients
(Preuss and Konno, 2002).
It is now conclusive that the anti-tumor effects are the result of the activity
of␣ various beta-glucans located in the fruit body and mycelium (the mass of
interwoven filaments that forms the vegetative portion of the mushroom in the
soil) (Ohno et al., 1985). Researchers have obtained various therapeutically
useful fractions by continually refining the elements from the fruiting body of
maitake. The results of much of this research were published in 1980s (Adachi
et al., 1987; Adachi et al., 1989; Nono et al., 1989; Ohno et al., 1984; Ohno
et␣ al., 1985; Suzuki et al., 1984; Suzuki et al., 1989).  The D-fraction of the
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maitake extract, obtained last, was found to possess the most potent anti-tumor
activity, leading to the highest reduction rate in cancer proliferation (Preuss and
Konno, 2002). Research on the specific beta-glucans found in the D-fraction
has demonstrated effects not only on macrophages but also on natural killer
cells and various T cells. Accordingly, the D-fraction demonstrates perhaps the
highest cancer inhibition of any source of beta-glucans via oral administration
(Adachi et al., 1987; Nono et al., 1989; Suzuki et al., 1989).
A literature review on maitake confirms that its natural polymer is an
important adjuvant in cancer therapeutics, for mitigating the damaging side
effects of chemotherapy and radiation, as well as for improving the body’s
innate defenses and improving the chances of living cancer-free. Another
way␣ that beta-glucans may add therapeutic benefit is by stimulation of tumor
inhibitors. In certain experimental models, systemic macrophage activation
and␣ certain cytokine releases seem to be critical for clearing tissues of tumor
cells and inhibiting metastasis. In 1995, Dr. Mitsuhiro Okazaki and co-
researchers (1995) demonstrated that the maitake mushroom stimulates
release,␣ or, rather, “primes” the body to release tumor-necrosis factor-alpha.
Additional studies have corroborated that maitake is a potent, broad-spectrum
cytokine inducer. In other words, maitake D-fraction exhibited an anti-tumor
effect on tumor-bearing mice through both enhanced cytotoxic activity and
stimulation of macrophages—helping the macrophages to function to their
fullest potential. This enhanced activity of macrophages invariably results in
elevated production of interleukin-1, thereby activating cytotoxic T lympho-
cytes and many additional cytokines. Finally, maitake has also been described
as possessing anti-angiogenic (Matsui et al., 2001) and apoptotic potential
(Konno, 2001).
In a non-randomized clinical study, 165 patients, aged 25 to 65, diagnosed
with various stages of cancers (III-IV) were given maitake D-fraction plus
crude␣ maitake powder tablets alone without chemotherapy or this same
combination along with chemotherapy (Nanba, 1995). Tumor regression or
significant improvements were observed among eleven out of fifteen breast-
cancer patients, twelve out of eighteen lung-cancer patients, and seven out
of␣ fifteen liver-cancer patients. If taken with chemotherapy, these response
rates␣ improved further by 12 to 28%. In several cases with both liver and
lung␣ cancer, the patients went from dangerous stage III status to more
manageable stages.
Recent studies in our laboratory using diabetic mice and rats further suggest
that maitake mushroom favorably affects diabetes mellitus and hypertension
(Manohar et al., 2002; Talpur et al., 2002). A group of eight diabetic Zucker
fatty rats given a fraction of maitake designated SX showed significantly
decreased systolic blood pressure and fasting blood-glucose levels when
compared to eight rats in a control group. At the end of six weeks, the
differences in systolic blood pressure between the two groups exceeded
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20 mm Hg; and the differences in fasting blood-glucose levels exceeded
60 mg/dL (218 mg/dL+18.3 (SEM) vs. 151 mg/dL+11.2). It is believed that
the␣ specific beta glucans in the water-soluble fraction SX were responsible for
these effects. Interestingly, the previously discussed fraction D, unlike fraction
SX, did not affect either of these parameters.
DEFINED POLLEN EXTRACT (CERNITIN)
Compared to another natural plant product, Serenoa repens (saw palmetto), a
defined flower pollen extract commonly called cernitin has received, up to now,
little recognition in the United States concerning its potential to benefit various
perturbations of the prostate. Ironically, it may be the best natural product for
this condition currently available. In 1950, a Swedish beekeeper found a way
to␣ collect pollen artificially (Preuss and Adderly, 1998). Since it seemed good
for bees, his hypothesis was that the defined pollen extract would be good for
humans. Initially, the flower pollen was used as a prophylactic agent against
infections. The extraction process was eventually modified so that the active
pollen was released and was non-allergenic. A water-soluble and an oil-soluble
fraction were deemed therapeutically useful. Oily cernitin GBX and water-
soluble cernitin T60 are a mixture of three different pollens—rye, timothy,
and␣ maize. Whatever the original hypothesis concerning overall health, the
defined pollen extract (cernitin) has proven useful specifically in treating
benign prostatic hyperplasia (BPH) (Loschen and Ebeling, 1991).
Leander (1962) published results of a carefully controlled clinical trial
of␣ cernitin. He compared placebo with cernitin pollen extract in 179 cases.
Using␣ defined pollen extract, he found a 60 to 80% improvement over placebo
in symptoms of obstruction, probably occurring through elimination of
inflammatory edema. In various subsequent clinical studies, a standardized,
allergen-free whole extract of selected Graminaceae pollen was found to be
suitable in the long-term treatment of prostatic congestion in BPH, chronic
prostatitis, and prostadynia (Leander, 1962; Ebeling, 1986; Becker and Ebeling,
1988). The usual dose in clinical studies is four to six tablets per day in divided
doses. Each tablet contains an average of 63 mg of Graminaceae pollen.
In 1986, a field study of 2,289 patients being treated by 170 urologists was
undertaken (Ebeling, 1986). The investigators examined the effectiveness
of␣ cernitin pollen extracts on chronic prostatitis and/or BPH. Improvement
of␣ symptoms was reported in 64 to 82%, in contrast to a low rate of adverse
reaction found only in 2.9 per cent of cases. In the same year, Brauer (1986)
compared the effects of cernitin and beta-sitosterol in thirty-nine patients.
A␣ significant reduction in circulating levels of prostate specific antigen (PSA)
with cernitin therapy indicated a reduction of cell lesions in BPH. In contrast,
no such change occurred with beta-sitosterol treatment. Although flower-pollen
extract proved superior to beta-sitosterol in many respects, the mean values
for␣ residual volume fell under 15 mL for both at the end of treatment.
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In a double-blind, placebo-controlled study performed in 1988 in collabora-
tion with six practicing urologists, Becker and Ebeling (1988) compared
forty-eight patients taking cernitin with an equal number of patients receiving
placebo over a 12-week period. Patients were classified as having stage II/III
BPH. Nocturia was claimed by 97% of the patients as a symptom. The results
showed that there was a significant improvement using cernitin compared to
placebo on nocturia, i.e. 69% vs. 37% (P <0.005). Not only the sensation of
residual urine but the actual volume of residual urine was significantly reduced
by flower-pollen extract. Mild nausea was reported in one patient. All in all,
the␣ “superiority of the active therapy is documented in the symptomatology,
the␣ results of the urodynamic investigations and by the global evaluation of the
therapy by both doctor and patient.”
In conjunction with two other clinical centers, we conducted a study using
a␣ combination of cernitin and saw palmetto to treat the symptoms of BPH. In a
randomized, double-blind, placebo-controlled study of 127 subjects (fifty-seven
placebo and seventy verum), we found statistically significant improvement in
nocturia, frequency, and overall prostate score by the American Urological
Association Symptom Index (Preuss et al., 2002).
A major mechanism behind the beneficial action of pollen extract is believed
to be inhibition of edema formation and prevention of inflammation in the
prostate. Inflammation of the prostate can cause edema of the interstitial tissue
surrounding the acini and ducts of the glands leading to poor drainage. This,
in␣ turn, creates difficult voiding, dysuria, frequency, and nocturia—symptoms
that have been shown to improve with defined flower-pollen extract usage.
In␣ addition, pollen extract has been reported to reduce prostatic volume and
residual volume, to improve voiding difficulties and increase urinary flow rates
of patients with BPH. Obviously, pain may result from such processes and will
remit to some extent if these perturbations are overcome. It is believed that
the␣ anticongestive action is based upon the inhibition of prostaglandin and
leukotriene biosynthesis. The activities of 5-lipoxygenase and cyclo-oxygenase
enzymes are markedly reduced and the arachidonic cascade is interrupted
(Loschen and Ebeling, 1991). Additional pharmacological effects reported
for␣ the pollen are: inhibition of prostate-cell growth in animals, influences on
contractility of bladder and urethral smooth muscle as well as diaphragms
of␣ animals, and effects on metabolism of dihydrotestosterone (Loschen and
Ebeling, 1991). In conclusion, the combined mechanisms behind the beneficial
effects of cernitin pollen extract will go a long way toward ensuring overall
prostate health.
ESSENTIAL OILS (CIDAL TO CANDIDA AND STAPHYLOCOCCUS)
It has been recognized for centuries that meat and fish can be preserved in
oils␣ obtained from various spice plants. In our laboratory, we examined the
ability of essential oils to kill the fungus Candida albicans, and the bacterium
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Staphylococcus aureus (Manohar et al., 2001). The experiments were carried out
both in vitro and in vivo. The spices examined included oregano, cinnamon/
cassia, myrtle, bay leaf, lavender, and cumin. Oregano and cinnamon were
found to be the most potent based on their ability to kill both Candida and
Staphylococcus in vitro at the lowest dilutions. When prevention of death of
mice infected with Candida was subsequently examined, a reasonable dose
of␣ oregano was found to save all the mice—similar to the effect of nystatin.
Carvacrol, believed to be the major active constituent in oregano, was also
shown in the same study to have therapeutic effects on the fungus. When the
mice were sacrificed after 30 days of daily treatment, they were found to be
clear of fungus with both nystatin and oregano.
In a second group of investigations, a dose of Staphylococcus was given that
killed all control mice within a 5-day period. All the mice receiving carvacrol
died eventually, but survived much longer, averaging 17 days. In contrast, half
(3/6) of the test mice survived for 30 days while taking daily doses of oregano.
Two of those receiving daily oral doses of vancomycin (2/6) survived the full
30␣ days and were free of Staphylococcus judged by postmortem examination
and␣ by kidney cultures.
MISCELLANEOUS USEFUL BOTANICALS
Other useful botanicals examined in our laboratory include:
• Wild garlic—a potential antihypertensive that works, at least in part,
through its inhibitory effects on angiotensin converting enzyme (ACE)
in␣ rats (Mohamadi et al., 2000; Preuss et al., 2001).
• Grape-seed extract—a powerful antioxidant that can reduce circulating
levels of the really bad cholesterol, oxidized LDL (Preuss et al., 2000).
• Cinnamon—a potential anti-diabetic and anti-hypertensive agent and
potentially fungicidal and bactericidal based on rodent studies (Berrio
et␣ al., 1992).
CONCLUSION
Many nutraceuticals offer a reasonable approach to prevent, ameliorate, or cure
chronic debilitating disorders safely and effectively.
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